SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 21, 16:15
617.60
-6.1 (-0.98%)
VOLUME 110,613
LIVE
NSE
Nov 21, 16:15
617.45
-6 (-0.96%)
VOLUME 1,528,026
Business News on Ranbaxy Laboratories
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
CCI begins public scrutiny of Holcim-Lafarge deal

2.25 pm | 22 Nov 2014 |  Source: PTI

The comments with respect to the Holcim-Lafarge deal need to be submitted to the CCI (Competition Commission of India) within 15 days, along with supp...

Ranbaxy sues FDA for revoking approvals for Nexium, Valcyte

2.55 pm | 18 Nov 2014 |  Source: Reuters

In the suit filed in the District Court for the District of Columbia, Ranbaxy said the FDA's move violated constitutional rights, exceeded the agency'...

Dr Reddy's, Endo get FDA approval to launch generic Valcyte

11.21 am | 07 Nov 2014 |  Source: Reuters

The US Food and Drug Administration (FDA) said it has granted final approval to Indian drugmaker Dr Reddy's Laboratories and US firm Endo Internationa...

Ranbaxy loses Valcyte exclusivity: An analysis 

10.14 am | 07 Nov 2014 |  Source: CNBC-TV18

Ranbaxy has first-to-file status, meaning eligibility for six months of generic sales exclusivity for both AstraZeneca's heartburn drug Nexium & Roche...

Ranbaxy loses 6 mths exclusivity for generic antiviral drug 

8.13 pm | 06 Nov 2014 |  Source: PTI

FDA has rescinded the previously granted tentative approvals for Ranbaxy's ANDAs for esomeprazole magnesium delayed-release capsules, 20 mg and 40 mg ...

Ranbaxy gets USFDA nod to sell cholesterol medicine

5.43 pm | 05 Nov 2014 |  Source: PTI

Commenting on the development, Ranbaxy Inc Trade Sales Vice President Dan Schober said: "The product will be manufactured at Ohm Laboratories, in our ...

LSE to delist Ranbaxy GDR programme with effect from Dec 15

12.12 pm | 01 Nov 2014 |  Source: PTI

Drug firm Ranbaxy Laboratories on Friday said Luxembourg Stock Exchange (LSE) will delist the company's Global Depository Receipts programme with effe...

India-targeted M&As touch $21.7 bn: Mergermarket

4.08 pm | 14 Oct 2014 |  Source: PTI

The value of India-targeted M&A for the entire 2014 is likely to surpass the 2013 annual total of USD 22.3 billion, said the global deal tracking firm...

12
Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.